Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.

MLA

Boisseau, William, et al. “Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.” The Oncologist, vol. 24, no. 12, Dec. 2019, pp. 1584–92. EBSCOhost, https://doi.org/10.1634/theoncologist.2019-0223.

APA

Boisseau, W., Euskirchen, P., Mokhtari, K., Dehais, C., Touat, M., Hoang-Xuan, K., Sanson, M., Capelle, L., Nouet, A., Karachi, C., Bielle, F., Guégan, J., Marie, Y., Martin-Duverneuil, N., Taillandier, L., Rousseau, A., Delattre, J.-Y., & Idbaih, A. (2019). Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. The Oncologist, 24(12), 1584–1592. https://doi.org/10.1634/theoncologist.2019-0223

Chicago

Boisseau, William, Philipp Euskirchen, Karima Mokhtari, Caroline Dehais, Mehdi Touat, Khê Hoang-Xuan, Marc Sanson, et al. 2019. “Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.” The Oncologist 24 (12): 1584–92. doi:10.1634/theoncologist.2019-0223.